Bushra Ijaz

Dr. Bushra Ijaz


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Phytomedicine
Verified
Journal Article
Closed access
FAFayyaz Ahmed
Fayyaz Ahmed
BIBushra Ijaz
Bushra Ijaz
ZAZarnab Ahmad
Zarnab Ahmad
NFNadia Farooq
Nadia Farooq
MSMuhammad Bilal Sarwar
Muhammad Bilal Sarwar
THTayyab Husnain
Tayyab Husnain

3 March 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SRSidra Rehman
Sidra Rehman
UAUsman Ali Ashfaq
Usman Ali Ashfaq
MSMuhammad Sufyan
Muhammad Sufyan
Imran ShahidImran Shahid
Imran Shahid
BIBushra Ijaz
Bushra Ijaz
MHMureed Hussain
Mureed Hussain
B. vulgaris extracts possess antioxidant, anti-inflammatory along with its role in improving memory disorders. Subsequently, in vitro and in silico studies of its purified phytochemicals may expand complementary and alternative Alzheimer’s therapeutic option. Super activation of acetylcholinesterase enzyme is associated explicitly with Alzheimer’s disease (AD) ultimately resulting in senile dementia. Hence, acetylcholinesterase enzyme inhibition is employed as a promising approach for AD treatment. Many FDA approved drugs are unable to cure the disease progression completely. The Present study was devised to explore the potential bioactive phytochemicals of B. vulgaris as alternative therapeutic agents against AD by conducting in vitro and in silico studies. To achieve this, chemical structures of phytochemicals were recruited from PubChem. Further, these compounds were analyzed for their binding affinities towards acetylcholinesterase (AChE) enzyme. Pharmacophoric ligand-based models showed major characteristics like, HBA, HBD, hydrophobicity, aromaticity and positively ionizable surface morphology for receptor binding. Virtual screening identified three hit compounds including betanin, myricetin and folic acid with least binding score compared to the reference drug, donepezil (-17 kcal/mol). Further, in vitro studies for anti-acetylcholinesterase activity of betanin and glycine betaine were performed. Dose response analysis showed 1.271 μM and 1.203 μM 50% inhibitory concentration (IC50) values for betanin and glycine betaine compounds respectively. Our findings indicate that phytoconstituents of B. vulgaris can be implicated as an alternative therapeutic drug candidate for cognitive disorders like Alzheimer’s disease.

Verified
Journal Article
Open access
PDF file
SNSobia Noreen
Sobia Noreen
SHSara Hasan
Sara Hasan
SGShazia Akram Ghumman
Shazia Akram Ghumman
Syed Nasir Abbas BukhariSyed Nasir Abbas Bukhari
Syed Nasir Abbas Bukhari
BIBushra Ijaz
Bushra Ijaz
Hasan EjazHasan Ejaz
Hasan Ejaz
The rapid progression in biomaterial nanotechnology apprehends the potential of non-toxic and potent polysaccharide delivery modules to overcome oral chemotherapeutic challenges. The present study is aimed to design, fabricate and characterize polysaccharide nanoparticles for methotrexate (MTX) delivery. The nanoparticles (NPs) were prepared by Abelmoschus esculentus mucilage (AEM) and chitosan (CS) by the modified coacervation method, followed by ultra-sonification. The NPs showed much better pharmaceutical properties with a spherical shape and smooth surface of 213.4–254.2 nm with PDI ranging between 0.279–0.485 size with entrapment efficiency varying from 42.08 ± 1.2 to 72.23 ± 2.0. The results revealed NPs to possess positive zeta potential and a low polydispersity index (PDI). The in-vitro drug release showed a sustained release of the drug up to 32 h with pH-dependence. Blank AEM -CS NPs showed no in-vivo toxicity for a time duration of 14 days, accompanied by high cytotoxic effects of optimized MTX loaded NPs against MCF-7 and MD-MBA231 cells by MTT assay. In conclusion, the findings advocated the therapeutic potential of AEM/CS NPs as an efficacious tool, offering a new perspective for pH-responsive routing of anticancer drugs with tumor cells as a target.

30 July 2024 in Functional & Integrative Genomics
Verified
Journal Article
Closed access
PDF file
MCMuhammad Waqas Choudry
Muhammad Waqas Choudry
RRRabia Riaz
Rabia Riaz
PNPashma Nawaz
Pashma Nawaz
MAMaria Ashraf
Maria Ashraf
BIBushra Ijaz
Bushra Ijaz
ABAllah Bakhsh
Allah Bakhsh

13 January 2026 in Drug Resistance Updates
Verified
Journal Article
Closed access
MTMuhammad Tufail
Muhammad Tufail
KGKunxiang Gong
Kunxiang Gong
BIBushra Ijaz
Bushra Ijaz
HPHarsh Patel
Harsh Patel
Weng-Onn LuiWeng-Onn Lui
Weng-Onn Lui
JLJie Li
Jie Li

1 June 2015 in Viral Immunology
Verified
Journal Article
Closed access
SNSobia Noreen
Sobia Noreen
IHIshtiaq Hussain
Ishtiaq Hussain
MTMuhammad Ilyas Tariq
Muhammad Ilyas Tariq
BIBushra Ijaz
Bushra Ijaz
SIShahid Muhammad Iqbal
Shahid Muhammad Iqbal
THTayyab Husnain
Tayyab Husnain
Hepatitis C virus (HCV) infection is a worldwide health problem affecting about 300 million individuals. HCV causes chronic liver disease, liver cirrhosis, hepatocellular carcinoma, and death. Many side effects are associated with the current treatment options. Natural products that can be used as anti-HCV drugs are thus of considerable potential significance. NS3 serine protease (NS3-SP) is a target for the screening of antiviral activity against HCV. The present work explores plants with anti-HCV potential, isolating possible lead compounds. Ten plants, used for medicinal purposes against different infections in rural areas of Pakistan, were collected. The cellular toxicity effects of methanolic extracts of the plants on the viability of Huh-7 cells were studied through the Trypan blue dye exclusion method. Following this, the anti-HCV potential of phytoextracts was assessed by infecting liver cells with HCV-3a-infected serum inoculum. Only the methanolic extract of Portulaca oleracea L. (PO) exhibited more than 70% inhibition. Four fractions were obtained through bioassay-guided extraction of PO. Subsequent inhibition of all organic extract fractions against NS3 serine protease was checked to track the specific target in the virus. The results showed that the PO methanolic crude and ethyl acetate extract specifically abridged the HCV NS3 protease expression in a dose-dependent fashion. Hence, PO extract and its constituents either alone or with interferon could offer a future option to treat chronic HCV.